Persistent Asset Partners LTD Pro Qr Therapeutics N.V. Transaction History
Persistent Asset Partners LTD
- $119 Billion
- Q1 2025
A detailed history of Persistent Asset Partners LTD transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 47,783 shares of PRQR stock, worth $77,886. This represents 0.05% of its overall portfolio holdings.
Number of Shares
47,783Holding current value
$77,886% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding PRQR
# of Institutions
68Shares Held
42.1MCall Options Held
30.1KPut Options Held
5.3K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.1MShares$13.2 Million0.02% of portfolio
-
Privium Fund Management B.V.4.99MShares$8.13 Million1.74% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.28MShares$5.35 Million0.49% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.07MShares$3.38 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.05MShares$3.35 Million1.03% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $116M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...